Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on December 27, 2006

Circulation. 2006
Published online before print December 27, 2006, doi: 10.1161/CIRCULATIONAHA.106.179294
A more recent version of this article appeared on January 2, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
115/1/114    most recent
CIRCULATIONAHA.106.179294v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buse, J. B.
Right arrow Articles by Stone, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buse, J. B.
Right arrow Articles by Stone, N. J.
Related Collections
Right arrow Nutrition
Right arrow Other hypertension
Right arrow Lipids
Right arrow Type 1 diabetes
Right arrow Type 2 diabetes
Right arrow Other diabetes
Right arrow Glucose intolerance
Right arrow Primary prevention
Right arrow Exercise/exercise testing/rehabilitation
Right arrow Exercise testing
Right arrow Risk Factors

Submitted on ,
Accepted on ,

Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus. A Scientific Statement From the American Heart Association and the American Diabetes Association

John B. Buse MD, PhD, Co-chair, Henry N. Ginsberg MD, FAHA, Co-chair, George L. Bakris MD, FAHA, Nathaniel G. Clark MD, MS, RD, Fernando Costa MD, FAHA, Robert Eckel MD, FAHA, Vivian Fonseca MD, Hertzel C. Gerstein MD, MSc, FRCPC, Scott Grundy MD, FAHA, Richard W. Nesto MD, FAHA, Michael P. Pignone MD, MPH, Jorge Plutzky MD, Daniel Porte MD, Rita Redberg MD, FAHA, Kimberly F. Stitzel MS, RD, and Neil J. Stone MD, FAHA

Abstract--The American Heart Association (AHA) and the American Diabetes Association (ADA) have each published guidelines for cardiovascular disease prevention: The ADA has issued separate recommendations for each of the cardiovascular risk factors in patients with diabetes, and the AHA has shaped primary and secondary guidelines that extend to patients with diabetes. This statement will attempt to harmonize the recommendations of both organizations where possible but will recognize areas in which AHA and ADA recommendations differ.


Key words: AHA Scientific Statement • cardiovascular diseases • diabetes mellitus • primary prevention




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
U. Campia and J. A. Panza
Flavanol-rich cocoa a promising new dietary intervention to reduce cardiovascular risk in type 2 diabetes?
J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2150 - 2152.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Y. Gasparyan, T. Watson, and G. Y.H. Lip
The Role of Aspirin in Cardiovascular Prevention: Implications of Aspirin Resistance
J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1829 - 1843.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. K. Schramm, G. H. Gislason, L. Kober, S. Rasmussen, J. N. Rasmussen, S. Z. Abildstrom, M. L. Hansen, F. Folke, P. Buch, M. Madsen, et al.
Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People
Circulation, April 15, 2008; 117(15): 1945 - 1954.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
A. Elis, L. Rosenmann, G. Chodick, A.D. Heymann, E. kokia, and V. Shalev
The association between glycemic, lipids and blood pressure control among Israeli diabetic patients
QJM, April 1, 2008; 101(4): 275 - 280.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. E. Inzucchi and D. K. McGuire
New Drugs for the Treatment of Diabetes: Part II: Incretin-Based Therapy and Beyond
Circulation, January 29, 2008; 117(4): 574 - 584.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. K. McGuire and S. E. Inzucchi
New Drugs for the Treatment of Diabetes Mellitus: Part I: Thiazolidinediones and Their Evolving Cardiovascular Implications
Circulation, January 22, 2008; 117(3): 440 - 449.
[Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
T. Amano, T. Matsubara, T. Uetani, M. Nanki, N. Marui, M. Kato, T. Yoshida, K. Arai, K. Yokoi, H. Ando, et al.
Abnormal Glucose Regulation Is Associated With Lipid-Rich Coronary Plaque: Relationship to Insulin Resistance
J. Am. Coll. Cardiol. Img., January 1, 2008; 1(1): 39 - 45.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. J. Bax, L. H. Young, R. L. Frye, R. O. Bonow, H. O. Steinberg, and E. J. Barrett
Screening for Coronary Artery Disease in Patients With Diabetes
Diabetes Care, October 1, 2007; 30(10): 2729 - 2736.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. M. Donahoe, G. C. Stewart, C. H. McCabe, S. Mohanavelu, S. A. Murphy, C. P. Cannon, and E. M. Antman
Diabetes and Mortality Following Acute Coronary Syndromes
JAMA, August 15, 2007; 298(7): 765 - 775.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
J. Lewis
Treating Diabetic Nephropathy: Unfinished Success Is Not Failure
Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 407 - 409.
[Full Text] [PDF]